Breakthrough in the synthesis of fungal bioactive compounds for therapeutic applications

Ataxia telangiectasia is a rare, inherited, progressive childhood disorder for which symptoms manifest neurologically and immunologically. Chromadex is developing a candidate to treat ataxia telangiectasia.

Gilead Sci­ences is well-known for its in­no­v­a­tive HIV and he­pati­tis med­ica­tions, but its pro­file is low­er in on­col­o­gy. The bio­phar­ma has been work­ing to change